ImmunoACT announces partnership with Mango Sciences to bring the world’s first bridge financing plan and value-based offering for CAR-T therapy for cancer patients in India
Mumbai (Maharashtra) , December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic...